Cardiovascular Systems, Inc. announced that it has appointed Rhonda Robb as its new Chief Operating Officer. She will report to Scott Ward, CSI Chairman, President and Chief Executive Officer. Robb formerly served as Vice President and General Manager of the Heart Valve Therapies business at Medtronic. In that role, she was responsible for the transcatheter and surgical valve franchises. Previously, Robb held additional leadership positions in Medtronic’s Coronary, Peripheral and Cardiac Rhythm businesses. She has strong experience leading complex businesses, growing new markets, extensive commercial experience, and a strong track record of building teams and product portfolios that have improved the quality of care for patients with cardiovascular disease. Robb replaces Kevin Kenny who will depart from CSI at the end of January 2018.